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Abstract. We have compared the behavior of wild-type 
mouse NEDD-2, a neural precursor cell--e_xpressed,  de- 
velopmentally down-regulated cysteine protease gene, 
to various mutant forms of the gene in both apoptotic 
activity in neuronal cells and proteolytic cleavage in the 
Semliki Forest virus and rabbit reticulocyte protein ex- 
pression systems. Our results confirm that NEDD-2 
processing and apoptotic activity are linked phenom- 
ena. They identify aspartate residues as likely targets 
for autocatalytic cleavage. They establish that cleavage 
events only occur at specific sites. Finally, they pinpoint 
differential effects of individual mutations on the 
overall proteolytic cleavage patterns, raising inter- 
esting questions related to the mechanisms of subunit 
assembly. 
O 
VER the past two years, proteolysis has emerged as 
an important mechanism underlying programmed 
cell death (PCD). 1 A major step toward the devel- 
opment of this concept has been the discovery of structural 
homology between interleukin (IL)-I~ converting enzyme 
(ICE), a protease involved in the processing of IL-113 pre- 
cursor in monocytes, and ced-3, a protein required for cells 
to undergo PCD in the nematode Caenorhabditis elegans 
(Yuan et al., 1993). ICE and ced-3 are prototypes of a fam- 
ily  of  cysteine  proteases  to  which  were  added  ICH-1/ 
NEDD-2 (Kumar et al., 1994; Wang et al., 1994), CPP32/ 
YAMA/Apopain (Fernandes-Alnemri et al., 1994; Tewari 
et  al.,  1995; Nicholson  et  al.,  1995),  TX/Ich-2/ICEIII 
(Munday et al., 1995; Faucheu et al., 1995; Kamens et al., 
1995), Mch2 (Fernandes-Alnemri et al., 1995a), and Mch3/ 
ICE LAP3 (Fernandes-Alnemri et al., 1995b; Duan et al., 
1996). There are several reasons to believe that these pro- 
teases play a  role in PCD:  (a)  their overexpression was 
shown to trigger PCD in diverse cell types (for review see 
Yuan, 1995);  (b) viral protein CrmA and p35, from cow- 
poxvirus  and baculovirus, respectively, can  inhibit cata- 
lytic activity of different members of this gene family, and 
thereby block PCD (Bump et al., 1995; Xue and Horvitz, 
1995; Martinou et al., 1995; Gagliardini et al., 1994); and 
Address all  correspondence to Bernard  Allet, Geneva Biomedical Re- 
search Institute, Glaxo Wellcome Research and Development S.A., 14, 
chemin des Aulx, 1228 Plan-Les-Ouates, Geneva, Switzerland. Tel.: (41) 
22 706 9666. Fax: (41) 22 794 6965. 
1.  Abbreviations  used in  this paper:  ICE,  interleukin-ll3 converting en- 
zyme; IL, interleukin; mut, mutant; PCD, programmed cell death; SFV, 
Semliki Forest virus; WT, wild type. 
(c) poly (ADP-ribose) polymerase and U1-70 K proteins, 
two  substrates  of these  proteases,  are  cleaved  early  in 
PCD (for review see Martin and Green, 1995). 
Most of the knowledge about the mechanism of action 
of cysteine proteases comes from studies on ICE. The ICE 
gene  product  is  a  45-kD  proenzyme that  requires  pro- 
teolytic processing for activation (Thornberry et al., 1992; 
Ceretti  et  al.,  1992).  Four  internal proteolytic cleavage 
sites at aspartate residues have been identified by protein 
sequencing (Thornberry et al., 1992),  resulting in the re- 
moval of an ll-kD NH2-terminal precursor domain and of 
an internal 19-amino acid sequence with concomitant pro- 
duction of two subunits of 20 and 10 kD. The crystal struc- 
ture of active ICE revealed that the protease is a tetramer 
of two p20 subunits surrounding two adjacent pl0 subunits 
that form the  dimer-dimer interface. The  active site of 
ICE comprises amino acid residues from both p20 and pl0 
polypeptides (Walker et al., 1994; Wilson et al., 1994; Gu 
et al., 1995). 
Structural  homologies between  members  of the  ICE 
family of proteases include a characteristic QACRG motif 
containing the catalytic cysteine residue (C285), and an ar- 
ray of aspartate residues, some of which are presumably 
targets for intramolecular cleavages. In ICE, a role for the 
C285  residue in  catalytic activity has  been  reported  by 
Thornberry et al. (1992).  In NEDD-2, the corresponding 
cysteine residue (C319) was shown to be required for apop- 
totic activity (Wang et al., 1994; Kumar et al., 1994), sug- 
gesting that it was, indeed, the protease  activity of this 
gene  that was  responsible  for mediating cell death.  To 
date, however, there have been no reports on the effects of 
mutations at the aspartate residues involved in intramolec- 
ular cleavages. 
© The Rockefeller University Press, 0021-9525/96/10/479/8  $2.00 
The Journal of Cell Biology, Volume 135, Number 2, October 1996 479-486  479 In this paper we describe a series of mutants of NEDD-2 
that affect either the catalytic cysteine or various aspartate 
residues, and we have analyzed the  ability of these mu- 
tants to promote an apoptotic response in primary cultures 
of neuronal cells. In parallel, we have compared the pro- 
teolytic cleavage products of the same mutants in two dif- 
ferent  test  situations:  (a)  overexpression in  CHO  cells 
driven by the Semliki Forest virus system and (b) the acel- 
lular  rabbit  reticulocyte  expression  system.  Our  results 
lead  to  several  conclusions.  First,  they  show  that  pro- 
teolytic cleavages occurring on both sides of the p20 sub- 
unit are necessary for biological activity. In addition, they 
identify aspartate residues that are targets for intramolec- 
ular cleavages and confirm specificity of these target sites 
by  eliminating  the  possibility  that  alternative  cleavage 
sites may be efficiently occurring. Finally, they pinpoint 
differential effects of mutations  on the  overall cleavage 
patterns. 
Materials and Methods 
Plasmids and Bacteria 
Plasmids were propagated in Escherichia  coil C600  (k) and purified by 
standard procedures (Maniatis et al., 1982). For expression under pL pro- 
moter, the plasmid constructs (Fig. 1 A) were transferred into E.coli B, a 
natural lon-prototroph (Allet et al., 1988). Plasmids pSFV-1 and pSFV- 
2-helper (Liljestrom and Garoff, 1991)  were provided by K. Lundstrom 
(Roche Institute, Basel, Switzerland), pEEl2 (Bebington and Hentschel, 
1987) was provided by C.R. Bebington (Celltech Ltd., Berkshire, UK), 
and pSP73 was purchased from Promega (Madison, WI). 
Cell Lines and Primary Cultures 
BHK-21 and CHO cell lines from the American Type Culture Collection 
(Rockville, MD) were grown in Ham's F-12/basal Iscove medium in a 1:1 
ratio (Seromed, Biochrom KG, Berlin, Germany) containing 10%  FCS 
and 4 mM glutamine. Sympathetic neuron primary cultures were estab- 
lished from superior mouse cervical ganglia and cultured as described pre- 
viously (Garcia et al., 1992). 
Cloning, PCR Technology, and Mutagenesis 
Enzymatic manipulations of DNA with restriction enzymes, calf intestine 
alkaline phosphatase, polynucleotide kinase, T4 DNA ligase, and T7 and 
SP6  RNA  polymerases were  as recommended by the suppliers. Basic 
methods of genetic engineering (gene cloning, purification of fragments, 
ligations, PCR  technology) were according to standard protocols (Au- 
subel et al., 1992). 
Oligonucleotides were prepared in  an  automated  DNA  synthesizer 
(ABI 394; Applied Biosystems, Foster City, CA) using the phosphoamid- 
ite chemistry according to the instructions recommended by the suppliers. 
The  NEDD-2  mutants were prepared by a  PCR  methodology. The 
template was wild type pEE12-NEDD-2 (Fig.  1 B) used in a  sufficient 
amount (50 ng) to reduce the number of cycles in DNA amplification to 
20. A common set of two synthetic oligonucleotides was used to prepare 
all the mutants. One oligonucleotide 0) corresponded to sequences in the 
upper strand, in a  region upstream from the unique SacI site, and the 
other, in the lower strand ®, in a region downstream from the XbaI site at 
the  translation  termination  site. The  lengths of these oligonucleotides 
were adapted to exhibit a melting temperature between 60  ° and 64°C, as- 
suming a melting temperature of 2°C for each A-T, and of 4  ° for each G-C 
base pairing. For each individual mutant, a set of two complementary oli- 
gonucleotides harboring the selected base alteration in the middle was 
synthesized (® and ®, upper and lower strand, respectively). In designing 
these oligonucleotides, a melting temperature of 30°-34°C was selected on 
each side of the mutated base. Two PCR reactions were set up, one with 
each of the mutated oligonucleotides combined with the appropriate com- 
mon oligonucleotide (i.e.,  ®-® and ®-®). The resulting amplified frag- 
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Figure 1.  Expression plasmids. Plasmid pBR  (A)  is for expres- 
sion in E.  coli,  pEEl2  (B)  in neuronal  cells, SFV-1  (C)  in  the 
Semliki Forest virus system, and SP73 (D) in the rabbit reticulo- 
cyte system. Promoters are indicated and  characteristic restric- 
tion  sites  (not  necessarily  unique)  used  in  constructions  are 
shown. 
ments were purified, combined (50 ng each), and used as template for a 
second round of PCR amplification using the set of common oligonucle- 
otides (® and ®). The amplified fragments were digested with a mixture 
of SacI and XbaI restriction enzymes, and the fragments were purified 
and cloned back in the original plasmid DNA by standard procedures. All 
constructs were confirmed by DNA sequencing. 
The residue Cys 320, present in the QACRG motif and assumed to be 
essential for the protease activity, was mutated to Ala. By analogy with 
other members of the cysteine protease gene family, catalytic cleavage 
sites must exist at aspartate residues to generate the so-called p20 and pl0 
subunits that assemble to form the active protein (Wilson et al,,  1994). 
The position of such residues in NEDD-2 was unknown, but Kumar et al. 
(1994)  had  identified numerous  potential candidates  (aspartate  D100, 
Dll6, D124, D135, D137, D159, D326, D330, D333, D347, and D362) on 
the basis of homologies with ICE. We have selected some of them to- 
gether with a few others for mutagenesis into Ala residues (Fig. 2). In par- 
allel, we used a  PCR-based procedure to construct three fragments as- 
sumed to encode both p20 and pl0 (T138  to T452),  p20 only (T138  to 
D333), or pl0 only (A348 to T452),  possibly fused to the linker sequence 
between p20 and pl0. The various mutants and gene fragments are shown 
in Fig. 2. They were subcloned into the plasmids shown in Fig. l, A-D. 
Polyclonal Antibodies against p20 
The NEDD-2 sequences from threonine 138 to aspartate 333, presumed to 
include the p20 subunit, were amplified by PCR. The synthetic oligonucle- 
otide at the amino terminus had a tail ending with a ClaI followed by an 
NdeI site (...ATCGATTCATATG).  On the opposite strand the oligonu- 
cleotide had a tail ending with a XbaI site followed by the CTA triplet cor- 
responding to the translation termination site. The amplified DNA was di- 
gested by the mixture of ClaI and Xbal restriction enzymes and subcloned 
into the corresponding sites of the pL plasmid (Fig. 1 A). The plasmid was 
propagated in C600  (h), transformed into E.coli B, and heat induced for 
expression. High expression was observed (~20% of total protein mass), 
and the polypeptide of 20 kD was found in the insoluble fraction (inclu- 
sion bodies) after sonication followed by centrifugation. This insoluble 
pellet from 1 L induced culture (~l g of wet cells) was dissolved in SDS- 
PAGE sample buffer and loaded on a preparative 18% gel. After electro- 
phoretie migration, the protein band of 20 kD was electroeluted in SDS- 
PAGE buffer, and the eluates (20-50 Ixg/ml) were used to raise polyclonal 
antibody in rabbits (Neosystems, Strasbourg, France). 
Efforts to prepare antibodies against pl0 (A348 to T452)  were unsuc- 
cessful because upon heat induction, the pl0 polypeptide was degraded 
into smaller products. We have not attempted to recover these degrada- 
tion products. 
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Figure  2.  Physical  map  of mutants  and  fragments.  The  figure 
summarizes  mapping  data  on  point  mutants  and  on  fragments 
that were either deliberately synthesized or were produced dur- 
ing processing in the SFV and rabbit reticulocyte expression sys- 
tems. The  upper  double bar represents the NEDD-2  gene  and 
shows wild-type amino  acids that  were  mutated  to  A  residues. 
The fragments selected for amplification by PCR are represented 
by smaller double bars under NEDD.  In the lower part, the gene 
fragments corresponding to the polypeptides of 17, 14, and 12 kD 
made in the SFV and reticulocyte systems are represented by sin- 
gle bars, and other processing products are shown by dotted lines. 
The starting site of the fragment of 17 kD (p20)  and of the pro- 
cessing product of 30 kD  is unknown  and indicated with an X; 
likewise, the end of the fragment of 18 kD is indicated by a ques- 
tion mark. 
Expression in the Semliki Forest Virus System 
The  pSFV-1 plasmid (Liljestrom and Garoff, 1991)  was engineered to 
contain a unique ClaI site followed by an XbaI site just downstream from 
the SP6 promoter. The wild-type and the mutant genes were cloned be- 
tween these sites (Fig. 1 C). In vitro RNA synthesis using pSFV-1 con- 
structs  and  pSFV-helper-2  as  templates,  and  coelectroporations  into 
BHK-21 cells, were as described (Liljestrom and Garoff, 1991). For suc- 
cessful infection with virus stocks in BHK-21 or CHO cells, it was im- 
portant that the cells be at 80% confluency. This was achieved by plat- 
ing  2  x  105  cells  in  35-mm  tissue-culture  plates  on  the  day  before 
infection. Infection, labeling with [3%]methionine at various times after 
infection, and cell lysis in the presence of protease inhibitors were con- 
ducted according to Liljestrom and Garoff (1991).  Samples corresponding 
to 4 x  104 cells per well were analyzed by SDS-PAGE in 4-20% gradient 
gels (Novex,  San  Diego,  CA).  The  proteins were  transferred electro- 
phoretically to nitrocellulose membranes, and the membranes were ex- 
posed directly to x-ray films (X-Omat AR; Eastman Kodak Co., Roches- 
ter, NY) in pulse-chase experiments, or alternatively analyzed by Western 
blotting. 
Western Blotting 
After transfer, the nitrocellulose membrane was blocked at room temper- 
ature for i h in a PBS solution containing 5% dried milk and 0.2% Tween-20 
(Bio Rad Laboratories, Hercules, CA). It was then immersed in a PBS so- 
lution containing the first antibody (i.e., polyclonal anti-p20) at  a  final 
concentration of 1.6 ~g/ml, 2.5% dried milk, and 0.1% Tween-20 for 1 h 
on a shaker platform. The membrane was washed three times for 15 min 
each in a PBS solution containing 0.2% Tween-20, and then transferred to 
a  PBS solution containing the second antibody (swine anti-rabbit IgG 
peroxidase), having otherwise the same composition as the first antibody. 
This incubation was for 2 h at room temperature on the shaking platform. 
After three cycles of washing as above, the membrane was developed with 
the enhanced chemiluminescence substrate (ECL; Amersham Intl., Little 
Chalfont, UK), as recommended, and exposed for a few seconds to Hyper 
film TM-ECL (Amersham Intl.). 
Expression in the Rabbit Reticulocyte System 
TNT coupled reticulocyte lysate system was purchased from Promega and 
used according to supplied instructions. Reaction mixtures (25  i~l) con- 
taining 0.5 p~g supercoiled plasmid DNA were incubated at 31°C in a ther- 
momixer (Eppendorf North America, Inc., Madison, WI) without agita- 
tion. After incubation for 2 h, the samples were diluted 20 times in 20 mM 
Hepes, pH 7.0, and vortexed. Aliquots (5-10 ~1) were mixed with equal 
volume of 2 × SDS-PAGE sample buffer and analyzed in 4-20% gradient 
gels. Gel transfer and autoradiography were as above. 
SP73-his-NEDD-2 
Vectors for fusing at the amino terminus a tag of 31 amino acids including 
6 histidine residues followed by an epitope for a defined mAb (X-Press) 
and a proteolytic cleavage site for enterokinase are commercially avail- 
able. By reassembling four synthetic oligonucleotides, we synthesized a 
DNA fragment incorporating the same characteristics, but with a coding 
capacity for 27 amino acids only, and restriction sites that facilitated inte- 
gration into our expression systems. Thus, this ClaI-NdeI synthetic frag- 
ment was ligated to the NEDD-2 gene contained in an Nde-XbaI frag- 
ment, and the fusion gene was inserted between the unique ClaI and XbaI 
site of pSP73 (Fig. 1 D). 
Resullts 
Cloning and Mutagenesis 
The NEDD-2 gene was cloned in our laboratory (M. Mis- 
sotten) from a  mouse thymus cDNA library (Stratagene, 
La Jolla,  CA)  using  an  oligonucleotide  probe based  on 
published data (Kumar et al., 1992). Compared to the gene 
described by Kumar et al. (1994), our clone contains an ex- 
tra codon for leucine  (CTC) at position 88 in the  amino 
acid sequence. Appropriate restriction sites were created 
at both ends by PCR  (Materials  and Methods),  and the 
full-length cDNA was cloned into plasmid vectors for ex- 
pression in E. coli, neuronal cells, and Semliki Forest virus 
and rabbit reticulocyte systems (Fig. 1, A-D). Mutants in 
the Cys 320 or in various aspartate residues, and gene frag- 
ments  including  different  combinations  of pl0  and  p20 
subunits,  were  prepared  as  described  in  Materials  and 
Methods. They are shown in Fig. 2. 
Survival Assays in Sympathetic Neurons 
Sympathetic neurons depend on NGF for survival (Garcia 
et al., 1992).  We first wanted to determine if overexpres- 
sion of wild-type (WT) NEDD-2 and mutant derivatives in 
these neurons could trigger cell death. To test it, we cul- 
tured sympathetic neurons for 5 d in the presence of NGF 
and microinjected them with the pEEl2 vector expressing 
separately each of the NEDD-2 mutants described above. 
24 h after injection, survival of neurons was measured on 
the basis of morphological criteria and expressed as a per- 
centage  of the  initial  number of neurons  (Garcia et  al., 
1992; Martinou et al., 1995). Fig. 3 shows that WT NEDD-2 
triggered programmed cell death of neurons, whereas the 
mutant NEDD-2c320n had no effect. Among the different 
mutants tested, D124A, D137A, D159A, and D347A be- 
haved  as  WT NEDD-2,  while  D135A,  D326A,  D330A, 
and D333A abolished the killing activity of NEDD-2 as ef- 
fectively as NEDD-2c320  A. Deletion of the first 137 amino 
acids (p20 +  10) also resulted in a loss of function of the 
protease. These results illustrate that the combination of 
mutagenesis and microinjection into sympathetic neurons 
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were cultured  for 5 d in the presence of NGF. In each experi- 
ment, at least 100 neurons were microinjected  with each DNA 
encoding  either WT NEDD-2,  NEDD-2c~20A, or the  different 
mutant at aspartate (D) residues.  24 h later,  neurons were ana- 
lyzed for survival on the basis of morphological criteria.  Results 
are mean -+ SD for two or three experiments. 
can  discriminate  between  functional  and  nonfunctional 
mutants. 
Expression and Cleavage in the Semliki Forest 
Virus System 
Semliki Forest virus (SFV)  is an overexpression system 
in which viral RNA containing the gene of interest is intro- 
duced into a cell by electroporation, where it then drives 
its own replication, capping, and translation so that mas- 
sive amounts  of the  protein  are produced.  Most protein 
synthesis is effectively shut  down at late stage, and  pro- 
cessing  of the  protein  in  question  will  clearly  not  have 
been subject to the same controls as in a normal cell. De- 
spite these features, the system has been used successfully 
in our laboratory to produce various chemokine (Banks 
et al.,  1995)  and neurokinin  receptors (Lundstrom et al., 
1994,  1995) whose biological activities were demonstrated 
on the whole infected cells by correct ligand binding and 
agonist/antagonist,  or  ion  trafficking,  responses.  These 
positive results encouraged us to test the technology with 
NEDD-2. 
The SFV expression system was handled as described by 
Liljestrom and Garoff (1991). In a first set of experiments, 
the RNA transcribed in vitro from the pSFV-helper-2 vec- 
tor was mixed with RNA transcribed from either pSFV1- 
NEDD-2 (WT) (Fig. 1 C) or pSFV1-NEDD-2c320A mutant 
(mut),  and  the  RNA  mixtures were  electroporated  into 
BHK-21 cells. Successful electroporations were monitored 
by pulse labeling with [35S]methionine, and the virus stocks 
were  harvested 24  h  later.  Aliquots  were  used in  pulse- 
chase  experiments  with  [35S]methionine  (Materials  and 
Methods)  to compare the total labeled proteins made at 
various  times  after infection.  A  viral stock expressing  a 
nonrelated  protein (IL8-R) was included  as control. The 
results are shown in Fig. 4. Strikingly, a protein of ~50 kD, 
corresponding to full-size NEDD-2, is detected in NEDD- 
2C3Z0A (mut) samples as early as 1 h after infection and still 
is the major component after 3 and 5 h. This full-size pro- 
tein  is not seen with WT NEDD-2,  but lower molecular 
mass species are detected: one of ~35 kD, and two others 
between  10  and 20 kD.  This result  raises the  interesting 
Figure  4.  Pulse-chase  labeling  analysis  of  WT  NEDD-2  and 
NEDD-2c320n polypeptide in SFV. Virus stocks expressing a con- 
trol  gene  (IL8  receptor),  WT  NEDD-2,  and  a  gene  mutant 
NEDD-2c320n were used to infect CHO cells at high multiplicity 
of infection.  The infected  cells were pulse labeled with [35S]me- 
thionine  at various times after infection. Aliquots (104 cells) were 
lysed  and submitted to SDS-PAGE (5-20%  acrylamide  gradi- 
ent); the proteins were transferred to a nitrocellulose  membrane 
and analyzed by radioautography as described  in Materials  and 
Methods.  The size markers on the righthand  side are 10 kD Pro- 
tein  Ladder  (10-200  kD)  from  GIBCO  BRL  (Gaithersburg, 
MD). Unprocessed NEDD-2 in the NEDD-2 mut lanes  (filled 
circles); two polypeptides between 10 and 20 kD in the lanes of 
NEDD  WT  (open  circles).  NEDD  WT,  wild-type  NEDD-2; 
NEDD mut, NEDD-2c320n. The origin of the strong band below 
50 kD seen especially at early times is unknown. 
possibility that a direct correlation may exist between the 
apoptotic activity described  in  the preceding section and 
the ability of NEDD-2 to be cleaved in the SFV system. 
In another experiment the same virus stocks were used 
to infect CHO cells, but pulse chase with [35S]methionine 
was omitted. Instead, the nonradioactive cells were lysed 
at  various  times  after  infection  and  submitted  to  SDS- 
PAGE. The proteins were transferred to a  nitrocellulose 
membrane  and  analyzed  by  Western  blotting  using  the 
polyclonal antibodies  raised  against p20,  as  described  in 
Materials and Methods. The results, shown in Fig. 5, con- 
firm and extend the previous data. Full-size NEDD-2 was 
largely predominant in the NEDD-2c320n samples, whereas 
smaller molecular mass species, mainly p20, were the ma- 
jor poplypeptides in WT NEDD-2. As expected, pl0 was 
not  detected  with  the  anti-p20  antibody.  In  the  WT 
NEDD-2  sample,  two  polypeptides  of ~30  and  35  kD 
were quite abundant.  Presumably, they represent specific 
cleavage  intermediates  that  contain  the  p20  sequence. 
Smaller molecular mass species  also  appeared  as  minor 
components  in  NEDD-2c320A,  notably  at  ~35  kD.  They 
may have arisen by cleavage at specific sites, but their in- 
ability to be converted into p20 would account for the lack 
of apoptotic activity observed with the mutant. 
The aspartate mutants (Fig. 2) were also tested both in 
pulse-chase  and  Western  blot  studies.  An  example  is 
shown in Fig. 6 where CHO cells were infected with SFV 
virus  stocks  prepared  in  parallel  and  expressing  WT 
NEDD-2, NEDD-2c320A,  and four aspartate mutants. The 
cells were analyzed by Western blotting 3 and 6 h after in- 
fection.  As  expected,  WT  NEDD-2  and  NEDD-2c320n 
show the same patterns as in Fig. 5.  Mutants D135A and 
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polypeptides in SFV. Duplicates  of the nonradioactive infected 
cells described  in Fig. 4 were lysed at the indicated times after in- 
fection  and submitted to SDS-PAGE (5-20% acrylamide gradi- 
ent); the proteins were transferred to a nitrocellulose  membrane, 
and the membranes were treated for Western blot analysis using 
the polyclonal  antibodies  against  p20 as described  in Materials 
and Methods.  As size markers (right), low range prestained SDS- 
PAGE standards from Bio Rad Laboratories were used:  phos- 
phorylase B (139.9 kD), BSA (86.8 kD), ovalbumin (47.8 kD), 
carbonic anhydrase  (33.3 kD),  soybean trypsin inhibitor  (28.6 
kD), and lysozyme (20.7 kD). The arrows on the lefthand side 
point to the positions  (from up to down) of uncleaved NEDD-2, 
the polypeptide of 35 kD, and the polypeptide (p20)  migrating 
faster than the 20.7-kD size marker. NEDD WT, WT NEDD-2; 
NEDD rout, NEDD-2c320A. 
D137A  are  poorly processed  and  resemble the  NEDD- 
2c320  A pattern. Whereas D135A was shown (Fig. 3) to be 
inactive  in  the  apoptotic test,  D137A  was  active in  this 
test. As can be seen in Fig. 6, however, D137A produces a 
low level of p20 6  h  after infection.  This would  indicate 
that  the  apoptotic test  in  neuronal  cells  can  respond  to 
rather low levels of p20. Processing of D159A and D347A 
seemed indistinguishable  from WT and produced  p20 as 
early as 3 h after infection, and both had a WT phenotype 
in the apoptotic test. 
The results described thus far argue that p20 is an essen- 
tial component that  correlates with biological activity as 
defined by the apoptotic assay in neuronal cells. The most 
convincing data derive from the Western blotting analyses 
using  the  anti-p20  antibodies.  Since  similar  antibodies 
against pl0 could not be obtained  (Materials  and Meth- 
ods),  analyses of the  smaller subunit  in  the  SFV system 
were limited to the examination of total radioactive pro- 
teins  synthesized  in  pulse-chase  experiments.  As  can  be 
seen  in  Fig.  4,  this  type  of analysis  suffered from back- 
ground problems that complicated unambiguous identifi- 
cation of the products. 
Expression and Cleavage in the Rabbit 
Reticulocyte System 
Rabbit reticulocyte  is  a  coupled transcription/translation 
system in which a plasmid DNA containing the gene of in- 
terest  under  the  control of a  bacteriophage  promoter is 
added to a  cellular extract supplemented with the appro- 
priate bacterial RNA polymerase. Because the balance of 
agonists or antagonists of any particular gene in the cellu- 
lar  extract  is  unknown,  processing  of the  corresponding 
Figure 6.  Comparative Western blot analysis  of aspartate mu- 
tants  in  SFV. Virus  stock  expressing  WT  NEDD-2,  NEDD- 
2C320A, and four D to A mutants were used to infect CHO cells 
and analyzed  by Western blots as described  in Fig. 5. The size 
markers (right) are as in Fig. 5. The arrow (left) points to the posi- 
tion  of uncleaved NEDD-2.  WT, WT NEDD-2; rout, NEDD- 
2C320  A.  The numbers indicate  the  mutants in  which  the corre- 
sponding aspartate has been replaced by an alanine residue. 
protein will, as in the SFV system, clearly not be subject to 
the same controls as in a  normal cell. Due to the ease of 
handling and product detection, however, the system has 
been commonly tested, notably with the ICE-like CPP32 
gene  (Fernandes-Alnemri  et  al.,  1994).  In a  preliminary 
experiment WT NEDD-2  and NEDD-2ca20  A were  intro- 
duced into the plasmid pSP73 (Fig. 1 D) and expressed in 
the  coupled  transcription/translation  rabbit  reticulocyte 
system (Promega) as described in Materials and Methods. 
Proteins  synthesized  in  the  presence  of  [35S]methionine 
were qualitatively similar to those obtained with the same 
genes analyzed by pulse-chase labeling in the SFV system 
(Fig. 4). Since the background is lower in this system, in- 
terpretation of the results is easier. As observed with the 
SFV expression system, the mutant gene yielded a major 
polypeptide  consistent  with  full-size  NEDD-2,  whereas 
the WT gene exhibited a number of smaller polypeptides, 
including the 35-kD polypeptide and the two polypeptides 
between  10  and  20  kD  seen with  the  SFV system. This 
prompted us to adopt the reticulocyte system for confirm- 
ing previous data and gaining information about pl0 and 
the cleavage intermediates. To permit identification of the 
products, we first compared WT NEDD-2 to a derivative, 
his-NEDD-2, in which a tag of 27 amino acids containing 
six adjacent histidine residues had been fused in phase to 
the amino terminus of WT NEDD-2 (Materials and Meth- 
ods). The results are shown in Fig. 7. Three polypeptides of 
12, 14, and 17 kD, which have the same size in the NEDD-2 
and his-NEDD-2 extracts, presumably do not include the 
amino terminus.  In  contrast,  the  polypeptides  of 18,  35, 
and 50 kD migrate as larger products in his-NEDD-2, and 
therefore  are  likely  to  contain  the  amino-terminal  se- 
quence. 
Size considerations suggest that the  18-kD polypeptide 
starts at the amino terminus and ends at a site upstream of 
the so-called p20 subunit, whereas the 35-kD protein is a 
cleavage intermediate  that  starts  at  the  amino  terminus 
and extends to a site downstream of p20 (Fig. 2). The 50-kD 
polypeptide  is  full-size,  uncleaved  NEDD-2.  Its  abun- 
dance relative to that of the cleavage products is signifi- 
cantly higher than when the same WT NEDD-2 gene was 
expressed in the  SFV system (Fig. 4), stressing the influ- 
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[35S]methionine-labeled  poly- 
peptides  containing  the  amino 
terminus of NEDD-2 in the rabbit 
reticulocyte  expression  system. 
Construction  of his-NEDD-2 is 
described  in  Materials  and 
Methods.  WT NEDD-2 and his- 
NEDD-2  in  SP73 (Fig.  1  D) 
were used as DNA templates in 
the coupled transcription-trans- 
lation rabbit reticulocyte  system 
and analyzed by SDS-PAGE (5- 
20% acrylamide gradient)  as de- 
scribed  in Materials  and Meth- 
ods.  The  proteins  were  trans- 
ferred to a nitrocellulose  membrane and exposed to x-ray film. 
The size markers (right) are the Rainbow 14C-methylated protein 
molecular  weight  markers  (Amersham  Intl.),  including  BSA 
(69.0 kD), ovalbumin  (46.0 kD), carbonic  anhydrase (30.0 kD), 
trypsin inhibitor  (21.5 kD), and lysozyme (14.3 kD). To facilitate 
further descriptions, the polypeptides  made from NEDD-2 were 
named  according  to  their  apparent  electrophoretic  mobility 
(left). 
ence that different test situations and/or cellular environ- 
ments may exert on the efficiency of proteolytic cleavage. 
The product identifications and size assignments in Fig. 7 
would imply that two of the three polypeptides identified 
between 10 and 20 kD represent the so-called pl0 and p20 
subunits,  the  presumed  active  components  of NEDD-2. 
Combined with the results presented below in Fig. 8, we 
propose that these active subunits migrate as polypeptides 
of 12 and 17 kD, and that the  14-kD polypeptide is a fu- 
sion that contains pl0 and a hypothetical linker region be- 
tween p20 and pl0 (Fig. 2). 
Fig. 8 shows the polypeptides made in the reticulocyte 
system from WT NEDD-2,  NEDD-2ca20A, and  seven as- 
partate  mutants  analyzed  in  parallel.  In  this  series, 
NEDD-2caEoA,  D135A, D330A, and D333A were all with- 
out effect on neuron survival (Fig. 3). As can be seen, they 
all fail to produce both 12-kD and 17-kD products. In ad- 
dition, NEDD-2caEoA  and D135A seem equally inefficient 
in  all  proteolytic  cleavages.  Surprisingly,  D137A,  which 
was active in  the  apoptotic assay, produces some 35-kD 
polypeptides, but  no  detectable  12- and  17-kD  polypep- 
tides. Since a low level of p20 (17 kD) was detected with 
this mutant in SFV (Fig. 6), we cannot exclude the possi- 
bility that this apparent lack of cleavage is inherent in the 
reticulocyte system and is not paralleled in neuronal cells. 
A  similar argument of system-dependent cleavage (or syn- 
thesis) may apply to D326. Inactive in the apoptotic assay, 
it  fails to  produce  the  12-kD  polypeptide,  but  seems to 
generate a low level of the 17-kD polypeptide. 
In designing mutants D330A,  D333A,  and D347A, we 
had  anticipated that the corresponding sites, lying in the 
area between p20 and pl0, might play an important role in 
NEDD-2 processing.  The  following results  entirely veri- 
fied  this  expectation.  Thus,  the  patterns  observed  with 
D330A and D333A support the hypothesis that they coin- 
cide  with the  cleavage site  at  the  righthand  side  of p20. 
Based on the assignments in Fig. 2, lack of cleavage at this 
site would be expected to result in three alterations of the 
Figure 8.  Mutant analysis in the rabbit reticulocyte  system. WT 
NEDD-2, NEDD-2¢aEOA, and the indicated  D  to A  mutants in 
SP73 were analyzed  in parallel  as described  in Fig. 7. WT, WT 
NEDD-2; mut, NEDD-2c320  A. 
WT pattern, namely, absence of the 35-kD product, fusion 
of 17- and  14-kD polypeptides to form a  30-kD product, 
and concomitant absence of 17- and 14-kD polypeptides. 
As  seen  in  the  figure,  these  alterations  are  indeed  ob- 
served. In addition, the 12-kD product is not made, sug- 
gesting that it cannot be cleaved directly from 30 kD, but 
requires  prior  formation of the  14-kD  polypeptide.  The 
pattern observed with the D347A mutant supports and ex- 
tends  these  interpretations.  The mutant  shares with WT 
NEDD-2 all the cleavage products except the  12-kD one 
(pl0).  Harboring intact  D330,  it produces,  as expected, 
the 35-, 18-,  17-, and 14-kD polypeptides. The inability to 
generate  the  12-kD  product  probably indicates  that  the 
mutated site coincides with the NH2-terminal boundary of 
the pl0 subunit. 
Fig.  9  shows  the  results  obtained  with  the  gene  frag- 
ments (Fig. 2) cloned into SP73 (Fig. 1 D) and analyzed as 
in Figs. 7 and 8. Fragment p(20 +  10) from T138 to T452 
migrates with an apparent molecular mass of 35 kD and is 
thus  larger  than  the  corresponding  30-kD  fragment  de- 
scribed in Fig.  8  with D330A  (D333A).  It is not cleaved 
into the  12- and  17-kD products.  Consistently, it did not 
show apoptotic activity in Fig. 3. Fragment p20, from T138 
to D333A,  migrates with an apparent molecular mass of 
about 20  kD, which  is  larger than  the  17-D  polypeptide 
Figure  9.  Analysis  of  PCR 
fragments in the rabbit retic- 
ulocyte  system.  The  three 
PCR fragments p(20  +  10), 
p20,  and  pl0  were  cloned 
into SP73 and analyzed  as in 
Figs. 7 and 8. Note that the 
PCR fragment p20 generates 
a  polypeptide  (arrow) that 
migrates significantly  slower 
than the so-called  p20 of 17 
kD  made  from  NEDD-2. 
Likewise, the PCR fragment 
p(20  +  10)  produces  a 
polypeptide migrating almost 
like the polypeptide of 35 kD 
made from NEDD-2. 
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the lefthand boundary of 17 kD at a site significantly distal 
relative to D135. In this context, mutant D159A failed to 
define this site by our biological activity and cleavage pat- 
tern criteria. We assume therefore that this site exists fur- 
ther downstream,  possibly at  aspartate  residue  D166  or 
D169. Fragment pl0, from A348 to T452, migrates almost 
like a 12-kD polypeptide and is consistent with the assign- 
ment of D347 at the NH2-terminal boundary of pl0. Fi- 
nally,  a  combination  of the  plasmids  pSP73  expressing 
p(20 +  10) and pl0 in the same reaction mixture did not 
affect the cleavage pattern. 
Discussion 
As a starting point for the present study, we knew the lo- 
cations of intramolecular cleavage sites in ICE at four as- 
partate  residues,  D103,  Dl19,  D297,  and  D316  (Thorn- 
berry et al.,  1992). However, because aspartate  residues 
are frequent in the family of cysteine proteases, this infor- 
mation did not permit us to predict with certainty the cor- 
responding sites  in  NEDD-2.  Thus,  it was  necessary to 
generate  a  rather  large  number  of mutants  to  identify 
these sites. Our task was greatly facilitated by the design of 
a PCR-based methodology that permitted rapid and effi- 
cient mutagenesis to obtain the desired derivatives (Mate- 
rials and Methods). 
Throughout the present study we have attempted to cor- 
relate activity and cleavage data using expression systems 
in which protein processing was likely to be subject to dif- 
ferent controls. A  priori, when extended to numerous ex- 
amples,  as  was  done  here,  this  particular  test  situation 
might have quickly led to ambiguous  interpretations. In 
fact, the internal consistency of almost all of the results 
based on these correlations argue that these system-borne 
differences were not so stringent as to invalidate the com- 
parisons, at least qualitatively. Therefore, even if the cho- 
sen systems do not mimic exactly the in vivo situation, and 
if the precise role and requirement for each protein frag- 
ment is still not understood, our observations support the 
conclusion that NEDD-2 processing and apoptotic activity 
are linked phenomena. Thus, wild-type NEDD-2 had, as 
expected, an apoptotic effect in the neuronal cells (Fig. 3), 
and it was processed to the p20 and pl0 subunits in the 
Semliki and reticulocyte systems (Figs. 4-9). In contrast, 
the cysteine mutant C320A showed no apoptotic activity 
in neuronal cells, as well as no processing in the Semliki 
Forest  virus  and  rabbit  reticulocyte  systems.  This  con- 
firmed the results of Kumar et al.  (1994) concerning the 
role of this cysteine residue in apoptosis and further sug- 
gested a link between apoptotic activity and correct pro- 
cessing. Like C320A, the mutant D135A showed no apop- 
totic activity (Fig. 3) and no proteolytic processing (Figs. 6 
and 8). The position of this site in NEDD-2 strongly sug- 
gests that it corresponds to D103 in ICE, defining one of 
the two cleavage sites upstream of p20. However, the fact 
that D135 mutant behaves like C320 mutant may lead to 
two alternative explanations: D135  is  a  cleavage site, or 
D135 mutation changes the overall structure of NEDD-2. 
The present  data  cannot  distinguish  between these  two 
possibilities.  Aspartate  mutants  D330A and D333A also 
lacked apoptotic activity (Fig. 3) and failed to produce p20 
and pl0 (Fig. 8). We assume that they define the cleavage 
site at the righthand side of p20 and correspond to the as- 
partate residue D297 in ICE. 
It has been shown recently (Ramage et al.,  1995) that 
the human ICE precursor of 45 kD made in E.  coli as an 
insoluble protein  (inclusion body) can be refolded, and 
that during the renaturation process it produces the p20 
and pl0 subunits without any additions other than reduc- 
ing agents. The authors concluded that the maturation of 
precursor  ICE  leading  to  the  active  p20-pl0  hetero- 
dimeric complex is  an  autocatalytic process.  Maturation 
proceeds in a time-dependent manner, and examination of 
the  intermediate  products  permits  prediction  about  the 
temporal order of cleavages. Our results showing that the 
mouse NEDD-2  gene expressed in two widely different 
systems gives rise to the same type of intermediate and fi- 
nal products support these conclusions and suggest that, 
perhaps, other members of the cysteine protease family 
modulate their activity through protein processing. 
Because no information was available about the cleav- 
age  specificity, we  were uncertain  if mutating  aspartate 
residues at cleavage sites would result in cleavage at neigh- 
boring  aspartate  residues  to  produce  novel  derivatives, 
possibly with altered apoptotic activity. Our results argue 
that a  high degree of specificity was retained. The most 
convincing examples are mutant D135A in the upstream 
region  of p20,  which  shows  no  processing,  and  D330A 
(D333A) at the end point of p20, which shows only the 
uncleaved products expected after eliminating this site. It 
is interesting to note that while D135A did abolish  all 
the cleavage events (same phenotype as C320A), mutant 
D330A and D333A did not prevent the cleavages at the 
sites upstream of p20 (Fig. 8). Whether or not this reflects 
an important feature in the mechanism of active protein 
formation from two precursor molecules is unknown. 
In  this  study the  aspartate  residue  that  identifies the 
NH2 terminus of pl0 was convincingly shown to lie at posi- 
tion  D347  (corresponding  to  D316  in  ICE),  as  mutant 
D347A exhibits all the polypeptides made for WT NEDD-2, 
except pl0, the polypeptide of 12 kD (Fig. 8). When tested 
in the biological neuronal assay, mutant D347A did pro- 
mote  an  efficient  apoptotic  response  indistinguishable 
from that of wild type. This raises the intriguing possibility 
that the polypeptide of 14 kD, a precursor of pl0, would 
be capable of forming an active heterodimer complex with 
p20. Further studies with the D347 mutant will hopefully 
help to clarify this point. 
In  the  present  study  three  of  the  four  autocatalytic 
cleavage sites in NEDD-2 have been identified. Thus, the 
dowstream aspartate residues D330 and D347 correspond 
to D297 and D316 in mouse ICE. Likewise, the upstream 
aspartate residue D135 in NEDD-2 corresponds to D103 
in ICE. The residue that defines the starting site of p20 
corresponding to aspartate Dl19 in ICE has escaped our 
analyses, but we know by size considerations that it exists 
at a position downstream of D159 (Fig. 2). 
Together, our results establish a  direct correlation be- 
tween biological activity and proteolytic cleavage of Nedd-2 
at specific sites. By showing differential effects of aspar- 
tate mutations on the overall cleavage patterns, these re- 
suits also open ways to dissect the yet poorly understood 
mechanisms of subunit formation and assembly. 
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